Nova Leap Health Stock Performance
| NLH Stock | CAD 0.25 0.01 3.85% |
Nova Leap has a performance score of 2 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.26, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Nova Leap's returns are expected to increase less than the market. However, during the bear market, the loss of holding Nova Leap is expected to be smaller as well. Nova Leap Health right now secures a risk of 3.53%. Please verify Nova Leap Health accumulation distribution, as well as the relationship between the day typical price and relative strength index , to decide if Nova Leap Health will be following its current price movements.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Nova Leap Health are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Nova Leap may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
1 | Nova Leap Health Showcases at MicroCap Event - TipRanks | 09/23/2024 |
2 | Nova Leap Health Corp. to Present at the LD Micro Main Event - Yahoo Finance | 10/21/2024 |
3 | Nova Leap Health Corp. entered into an agreement to acquire Earth Angels Living Assistance Inc.Earth Angels South Shore Inc. for CAD 1.38 million. - Marketscree... | 11/20/2024 |
| Begin Period Cash Flow | 2.2 M |
Nova |
Nova Leap Relative Risk vs. Return Landscape
If you would invest 24.00 in Nova Leap Health on September 1, 2024 and sell it today you would earn a total of 1.00 from holding Nova Leap Health or generate 4.17% return on investment over 90 days. Nova Leap Health is currently producing 0.1259% returns and takes up 3.5275% volatility of returns over 90 trading days. Put another way, 31% of traded stocks are less volatile than Nova, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Nova Leap Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nova Leap's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nova Leap Health, and traders can use it to determine the average amount a Nova Leap's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0357
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | NLH | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.53 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.13 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Nova Leap is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nova Leap by adding it to a well-diversified portfolio.
Nova Leap Fundamentals Growth
Nova Stock prices reflect investors' perceptions of the future prospects and financial health of Nova Leap, and Nova Leap fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nova Stock performance.
| Return On Equity | -0.0249 | ||||
| Return On Asset | 0.0279 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 21.31 M | ||||
| Shares Outstanding | 86.21 M | ||||
| Price To Book | 0.84 X | ||||
| Price To Sales | 0.84 X | ||||
| Revenue | 26.41 M | ||||
| Gross Profit | 9.98 M | ||||
| EBITDA | 1.23 M | ||||
| Net Income | (1.07 M) | ||||
| Cash And Equivalents | 1.24 M | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 3.97 M | ||||
| Debt To Equity | 64.80 % | ||||
| Current Ratio | 0.58 X | ||||
| Book Value Per Share | 0.21 X | ||||
| Cash Flow From Operations | 1.41 M | ||||
| Earnings Per Share | (0.02) X | ||||
| Market Capitalization | 23.28 M | ||||
| Total Asset | 23.95 M | ||||
| Retained Earnings | (1.19 M) | ||||
| Working Capital | (10.37 K) | ||||
About Nova Leap Performance
Evaluating Nova Leap's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Nova Leap has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nova Leap has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 32.41 | 35.24 | |
| Return On Tangible Assets | (0.18) | (0.19) | |
| Return On Capital Employed | 0.02 | 0.03 | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | (0.06) | (0.06) |
Things to note about Nova Leap Health performance evaluation
Checking the ongoing alerts about Nova Leap for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nova Leap Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nova Leap Health has some characteristics of a very speculative penny stock | |
| Nova Leap Health had very high historical volatility over the last 90 days | |
| The company has C$3.97 Million in debt which may indicate that it relies heavily on debt financing | |
| Nova Leap Health has accumulated 3.97 M in total debt with debt to equity ratio (D/E) of 64.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Nova Leap Health has a current ratio of 0.57, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Nova Leap until it has trouble settling it off, either with new capital or with free cash flow. So, Nova Leap's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nova Leap Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nova to invest in growth at high rates of return. When we think about Nova Leap's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 26.41 M. Net Loss for the year was (1.07 M) with profit before overhead, payroll, taxes, and interest of 9.98 M. | |
| About 41.0% of Nova Leap outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Nova Leap Health Corp. entered into an agreement to acquire Earth Angels Living Assistance Inc.Earth Angels South Shore Inc. for CAD 1.38 million. - Marketscreener.com |
- Analyzing Nova Leap's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nova Leap's stock is overvalued or undervalued compared to its peers.
- Examining Nova Leap's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nova Leap's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nova Leap's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nova Leap's stock. These opinions can provide insight into Nova Leap's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Nova Stock Analysis
When running Nova Leap's price analysis, check to measure Nova Leap's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Leap is operating at the current time. Most of Nova Leap's value examination focuses on studying past and present price action to predict the probability of Nova Leap's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Leap's price. Additionally, you may evaluate how the addition of Nova Leap to your portfolios can decrease your overall portfolio volatility.